Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 2 | BMC Molecular and Cell Biology

Fig. 2

From: Canine intestinal organoids as a platform for studying MHC class II expression in epithelial cells

Fig. 2

MHC class II gene expression in colonoids after treatment with the three major proinflammatory cytokines. (A) A schematic representation of the flow of cytokine treatments. The colonoids were initially cultured for 2 days in EM, followed by changing the medium from EM to DM. On day 4, colonoids were treated with 30 ng/mL of recombinant canine IFN-γ, TNF-α, or IL-1β in either EM or DM for 24 h. This schematic was created using BioRender.com. (B) The representative image of the canine colonoids at 24 h after treatment with 30 ng/mL of IFN-γ, IL-1β and TNF-α in EM and DM. Scale bar = 50 μm. (C) DLA-DRA expression was quantified using RT-qPCR 24 h after cytokine treatment (30 ng/mL IFN-γ, IL-1β, or TNF-α) in EM or DM. Three biological replicates were used for this analysis, with each cytokine treatment performed in triplicate. Error bars represent the SEM. **p < 0.01

Back to article page